Is the price fair?
What WST's price assumes
West Pharmaceutical Services trades at 46.8× earnings against 42.5× for the median Medical Instruments & Supplies name, more expensive than its own group.
46.8
Trailing P/E · Medical Instruments & Supplies median 42.5 · 1.10× the median: the market pays up for this one
- Price / sales
- 5.63
Price / sales · as of 2026-Q1
- Free cash flow yield
- 2.0%
Free cash flow yield · Medical Instruments & Supplies median 3.7%
- Growth the price implies
- +18%
Growth the price implies · The price pays for +18% free cash flow growth a year for a decade; the business has delivered +3.8% a year over the last three.
Details›
- Price / book2026-Q1
- 6.06
- EV / EBIT2026-Q1
- 27.2
- EV / sales2026-Q1
- 5.53
- Healthcare median P/E362 names
- 31.5
- Medical Instruments & Supplies median P/E29 names
- 42.5
- Free cash flow, trailing twelve months
- $458M
- Market capitalisation
- $23.2B
- 3-year revenue growth
- +3.8%
- 3-year free cash flow growth
- +3.8%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $300.42 |
| Its own P/E history, median | $334.81 |
| Its own P/E history, upper quartile | $368.09 |
| 52-week range | $230.78 – $362.41 |
| Today | $350.14 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Instruments & Supplies
Ranks #4 of 27 by Smart Score